Statements (53)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:can_lead_to |
infections
organ failure compromised immune system |
gptkbp:can_metastasize_to |
after treatment
if not fully treated |
gptkbp:caused_by |
environmental factors
genetic mutations viral infections |
https://www.w3.org/2000/01/rdf-schema#label |
high-grade lymphoma
|
gptkbp:is_associated_with |
gptkb:HIV/_AIDS
autoimmune diseases certain infections |
gptkbp:is_characterized_by |
high proliferation index
presence of Reed-Sternberg cells rapid growth of lymphatic cells |
gptkbp:is_monitored_by |
imaging studies
regular follow-up appointments blood tests for tumor markers |
gptkbp:is_often_used_in |
adults
men |
gptkbp:is_part_of |
cancer types
lymphatic system disorders |
gptkbp:is_protected_by |
avoiding known risk factors
early detection and treatment of infections |
gptkbp:is_studied_in |
clinical trials
oncology research |
gptkbp:managed_by |
oncologists
hematologists |
gptkbp:notable_for |
high response rates to treatment
potential for cure with aggressive treatment varied clinical presentations |
gptkbp:occurs_in |
gptkb:Person
|
gptkbp:scientific_classification |
gptkb:healthcare_organization
gptkb:aggressive_lymphoma gptkb:non-Hodgkin_lymphoma |
gptkbp:social_responsibility |
blood tests
biopsy imaging tests variable prognosis |
gptkbp:symptoms |
fatigue
weight loss fever night sweats swollen lymph nodes |
gptkbp:treatment |
gptkb:vaccine
radiation therapy chemotherapy targeted therapy stem cell transplant clinical trials for new drugs |
gptkbp:bfsParent |
gptkb:T-cell_lymphoblastic_lymphoma
|
gptkbp:bfsLayer |
6
|